NDC 75907-075-28 - ERRIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 75907-075
- Requested NDC
- 75907-075-28
- Package NDCs from labels
- 75907-075-28, 75907-075-32
- Manufacturer
- Dr. Reddy's Labratories Inc.
- Effective date
- 2024-03-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ERRIN ® (NORETHINDRONE TABLETS USP, 0.35 MG) | Dr. Reddy's Labratories Inc. | 2024-03-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75907-075-28 | ERRIN | 28 in 1 BLISTER PACK | TABLET | 28 | 1 | |
| 75907-075-32 | ERRIN | 3 in 1 CARTON | TABLET | 3 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 75907-075-28 | EA - Each | 75907-075 | 58636e75-a92a-4f59-adbd-08f04b5b3b4d | 1 | 2024-06-10 |
| 75907-075-32 | EA - Each | 75907-075 | bcaad4f1-a360-4fd0-b619-b0a5a4661037 | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Emzahh | NORETHINDRONE | Aurobindo Pharma Limited | 197d31d3-eec8-49c7-9640-918ff138fea2 | 2023-04-10 | Warnings, Adverse reactions | 748961 198042 T18F433X4S |
| Lyleq | NORETHINDRONE | Afaxys Pharma, LLC | c9f00a3e-c827-4066-bf85-079b3a20f25e | 2023-03-27 | Warnings, Adverse reactions | 748961 198042 T18F433X4S |
| Nortrel 28 Day | NORETHINDRONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | 140c50d6-c931-423a-9aa0-526eae7ab93c | 2021-12-01 | Boxed warning, Warnings, Adverse reactions | T18F433X4S |
| Incassia | NORETHINDRONE | Aurobindo Pharma Limited | 0b87cef0-610c-469d-92ba-4007f4bc3878 | 2021-09-14 | Warnings, Adverse reactions | 748961 198042 T18F433X4S |
| Norethindrone | NORETHINDRONE | Proficient Rx LP | fb84b86e-5f1f-4c17-8b69-ff695c5faf55 | 2019-11-01 | Warnings, Adverse reactions | 748961 198042 T18F433X4S |
| NORETHINDRONE | NORETHINDRONE | Mylan Pharmaceuticals Inc. | af851d82-b30f-463b-9dba-0437225dc1ee | 2018-10-23 | Boxed warning, Warnings, Adverse reactions | 748961 198042 T18F433X4S |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.